Vanguard Group
INFI

Vanguard Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Vanguard Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,981,857
Closed -$838K – 4580
2023
Q2 		$838K Sell
3,981,857
-13,017
-0.3% -$2.26K ﹤0.01% 3953
2023
Q1 		$639K Sell
3,994,874
-1,318,805
-25% -$586K ﹤0.01% 4048
2022
Q4 		$2.95M Buy
5,313,679
+1,990
+0% +$1.69K ﹤0.01% 3521
2022
Q3 		$6.32M Buy
5,311,689
+40,773
+0.8% +$44K ﹤0.01% 3197
2022
Q2 		$3.33M Sell
5,270,916
-514,372
-9% -$395K ﹤0.01% 3576
2022
Q1 		$6.59M Buy
5,785,288
+1,855
+0% +$2.22K ﹤0.01% 3378
2021
Q4 		$13M Buy
5,783,433
+225,274
+4% +$565K ﹤0.01% 3082
2021
Q3 		$19M Buy
5,558,159
+1,175,354
+27% +$3.62M ﹤0.01% 2892
2021
Q2 		$13.1M Buy
4,382,805
+838,751
+24% +$2.65M ﹤0.01% 3067
2021
Q1 		$11.4M Buy
3,544,054
+1,214,113
+52% +$4.05M ﹤0.01% 3078
2020
Q4 		$4.94M Buy
2,329,941
+16,948
+0.7% +$28K ﹤0.01% 3361
2020
Q3 		$2.71M Hold
2,312,993
– – ﹤0.01% 3398
2020
Q2 		$2.09M Hold
2,312,993
– – ﹤0.01% 3418
2020
Q1 		$1.94M Hold
2,312,993
– – ﹤0.01% 3322
2019
Q4 		$2.22M Hold
2,312,993
– – ﹤0.01% 3422
2019
Q3 		$2.38M Hold
2,312,993
– – ﹤0.01% 3393
2019
Q2 		$4.16M Hold
2,312,993
– – ﹤0.01% 3229
2019
Q1 		$4.35M Buy
2,312,993
+180,745
+8% +$264K ﹤0.01% 3187
2018
Q4 		$2.52M Sell
2,132,248
-53,575
-2% -$96.3K ﹤0.01% 3302
2018
Q3 		$5.92M Buy
2,185,823
+6,168
+0.3% +$12.8K ﹤0.01% 3168
2018
Q2 		$4.16M Buy
2,179,655
+194,417
+10% +$393K ﹤0.01% 3265
2018
Q1 		$4.17M Buy
1,985,238
+90,319
+5% +$194K ﹤0.01% 3218
2017
Q4 		$3.85M Sell
1,894,919
-454,045
-19% -$942K ﹤0.01% 3233
2017
Q3 		$3.12M Sell
2,348,964
-2,278,681
-49% -$2.83M ﹤0.01% 3277
2017
Q2 		$7.26M Sell
4,627,645
-74,124
-2% -$143K ﹤0.01% 2927
2017
Q1 		$15.2M Buy
4,701,769
+1,021,128
+28% +$2.51M ﹤0.01% 2565
2016
Q4 		$4.97M Sell
3,680,641
-2,221,412
-38% -$2.9M ﹤0.01% 3068
2016
Q3 		$9.21M Sell
5,902,053
-693,696
-11% -$1.07M ﹤0.01% 2729
2016
Q2 		$8.77M Sell
6,595,749
-108,894
-2% -$509K ﹤0.01% 2715
2016
Q1 		$35.3M Buy
6,704,643
+473,831
+8% +$2.9M ﹤0.01% 2033
2015
Q4 		$48.9M Buy
6,230,812
+618,924
+11% +$5.33M ﹤0.01% 1893
2015
Q3 		$47.4M Buy
5,611,888
+155,225
+3% +$1.43M ﹤0.01% 1896
2015
Q2 		$59.8M Buy
5,456,663
+633,819
+13% +$8.13M ﹤0.01% 1836
2015
Q1 		$67.4M Buy
4,822,844
+1,337,827
+38% +$20.5M ﹤0.01% 1769
2014
Q4 		$58.9M Buy
3,485,017
+761,484
+28% +$11.1M ﹤0.01% 1749
2014
Q3 		$36.5M Buy
2,723,533
+18,246
+0.7% +$217K ﹤0.01% 1961
2014
Q2 		$34.5M Buy
2,705,287
+47,288
+2% +$493K ﹤0.01% 2009
2014
Q1 		$31.6M Buy
2,657,999
+119,805
+5% +$1.61M ﹤0.01% 2030
2013
Q4 		$35.1M Buy
2,538,194
+78,796
+3% +$1.11M ﹤0.01% 1950
2013
Q3 		$42.9M Buy
2,459,398
+66,548
+3% +$1.27M ﹤0.01% 1807
2013
Q2 		$38.9M Buy
+2,392,850
New +$74M ﹤0.01% 1790

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Vanguard Group's INFI Position: Q3 2023 in Review

Vanguard Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 3,981,857 shares — an estimated $838K sold.

Vanguard Group first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $67.4M in Q1 2015. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Vanguard Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 3,981,857 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $838K.
  • Vanguard Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
  • Vanguard Group's Infinity Pharmaceuticals, Inc. position peaked at $67.4M in Q1 2015.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.